ESR1 and breast cancer: Triple negative breast cancer (TNBC) accounts for 15-20% of breast cancer cases and is defined by the lack of estrogen receptor alpha (ERα) and progesterone receptor (PR) expression and the absence of Her2 overexpression/amplification.